Literature DB >> 32737654

Accuracy of death certificates for recording parkinsonian syndromes and associated dementia.

Hanxu Shi1, Carl Counsell2.   

Abstract

INTRODUCTION: Death certification is often used to identify patients with certain diseases in epidemiologic research. There have been few studies looking at the accuracy of recording of parkinsonian diagnoses, any associated dementia and the cause of death on death certificates in people with parkinsonian conditions. This study aimed to assess this.
METHODS: Data for these analyses were derived from a prospective incident cohort of degenerative/vascular parkinsonian syndromes with lifelong follow-up from Scotland, UK (the PINE study). In those who died, the available research and clinical care records were reviewed to establish the cause for each patient's death. The sensitivity of death certificates was calculated to detect any parkinsonian diagnosis mentioned on the death certificate, the correct specific diagnosis and the presence of dementia. The causes of death were compared between clinical records and death certificates.
RESULTS: Two hundred and seventy-seven patients had died (180 men), mean age at diagnosis and death 76.9 years and 81.9 years respectively. 66.8% of death certificates mentioned any parkinsonian syndrome but only 49.5% had the correct diagnosis. Sensitivity was highest for Parkinson's disease, those who had parkinsonian-related deaths, had longer disease durations and died out of hospital. Death certificates detected 51.2% of those with dementia. The commonest causes of death were pneumonia, end-stage Parkinsonism and vascular disease with moderate agreement between case-note review and death certification.
CONCLUSION: Deaths certificates often do not mention underlying Parkinsonism or associated dementia and so epidemiological studies should not rely on this as a sole method of identifying cases or studying mortality.

Entities:  

Keywords:  Accuracy; Death certificates; Dementia; Parkinsonian disorders; Sensitivity

Mesh:

Year:  2020        PMID: 32737654     DOI: 10.1007/s00415-020-10113-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  16 in total

Review 1.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Authors:  I Litvan; Y Agid; D Calne; G Campbell; B Dubois; R C Duvoisin; C G Goetz; L I Golbe; J Grafman; J H Growdon; M Hallett; J Jankovic; N P Quinn; E Tolosa; D S Zee
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

2.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

3.  Death certificate data and causes of death in patients with parkinsonism.

Authors:  Mariana Moscovich; Gabriela Boschetti; Adriana Moro; Helio A G Teive; Anhar Hassan; Renato P Munhoz
Journal:  Parkinsonism Relat Disord       Date:  2017-05-26       Impact factor: 4.891

Review 4.  Parkinsonian syndromes.

Authors:  David R Williams; Irene Litvan
Journal:  Continuum (Minneap Minn)       Date:  2013-10

Review 5.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

6.  Mortality and quality of death certification in a cohort of patients with Parkinson's disease and matched controls in North Wales, UK at 18 years: a community-based cohort study.

Authors:  Peter Hobson; Jolyon Meara
Journal:  BMJ Open       Date:  2018-02-14       Impact factor: 2.692

Review 7.  Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in northeast Scotland: the PINE study.

Authors:  Robert Caslake; Kate Taylor; Neil Scott; Joanna Gordon; Clare Harris; Katie Wilde; Alison Murray; Carl Counsell
Journal:  Parkinsonism Relat Disord       Date:  2013-02-23       Impact factor: 4.891

Review 8.  Mortality in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Angus D Macleod; Kate S M Taylor; Carl E Counsell
Journal:  Mov Disord       Date:  2014-05-13       Impact factor: 10.338

9.  The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia.

Authors:  Kajsa Stubendorff; Dag Aarsland; Lennart Minthon; Elisabet Londos
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

10.  Reporting of clinically diagnosed dementia on death certificates: retrospective cohort study.

Authors:  Gayan Perera; Robert Stewart; Irene J Higginson; Katherine E Sleeman
Journal:  Age Ageing       Date:  2016-05-04       Impact factor: 10.668

View more
  3 in total

Review 1.  A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes.

Authors:  G Bellomo; P Piscopo; M Corbo; E Pupillo; G Stipa; E Beghi; N Vanacore; E Lacorte
Journal:  Neurol Sci       Date:  2022-08-17       Impact factor: 3.830

2.  Parkinson's disease related mortality: Long-term trends and impact of COVID-19 pandemic waves.

Authors:  Ugo Fedeli; Veronica Casotto; Claudio Barbiellini Amidei; Mario Saia; Silvia Netti Tiozzo; Cristina Basso; Elena Schievano
Journal:  Parkinsonism Relat Disord       Date:  2022-04-25       Impact factor: 4.402

3.  Worldwide trends in mortality related to Parkinson's disease in the period of 1994-2019: Analysis of vital registration data from the WHO Mortality Database.

Authors:  Ioannis C Lampropoulos; Foteini Malli; Olga Sinani; Konstantinos I Gourgoulianis; Georgia Xiromerisiou
Journal:  Front Neurol       Date:  2022-10-04       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.